AMENDMENT TO SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • April 26th, 2019 • Innovate Biopharmaceuticals, Inc. • Pharmaceutical preparations • New York
Contract Type FiledApril 26th, 2019 Company Industry JurisdictionThis Amendment (this “Amendment”), dated April 25, 2019, amends the Securities Purchase Agreement (the “Agreement”), dated as of March 17, 2019, by and among Innovate Biopharmaceuticals, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages thereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”). Capitalized terms used but not otherwise defined herein shall have the meanings ascribed to such terms in the Agreement.